ArticlePloS one2014

Relapse rates in patients with multiple sclerosis switching from interferon to fingolimod or glatiramer acetate: a US claims database study.

Niklas Bergvall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.